• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma.已有青光眼患者发生视网膜中央静脉阻塞后的新生血管性青光眼。
BMC Ophthalmol. 2014 Oct 5;14:119. doi: 10.1186/1471-2415-14-119.
2
Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma.视网膜中央静脉阻塞、原发性开角型青光眼和新生血管性青光眼患者的电生理评估和视觉预后。
Acta Ophthalmol. 2010 Feb;88(1):86-90. doi: 10.1111/j.1755-3768.2008.01424.x. Epub 2009 Apr 27.
3
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.玻璃体内注射贝伐单抗治疗41例连续性缺血性视网膜疾病继发的虹膜新生血管和新生血管性青光眼。
Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.
4
Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.视网膜中央静脉阻塞新生血管性青光眼的预测因素。
Am J Ophthalmol. 2019 Aug;204:62-69. doi: 10.1016/j.ajo.2019.02.038. Epub 2019 Mar 9.
5
Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.全视网膜光凝联合冷冻视网膜固定术或玻璃体腔内贝伐单抗治疗新生血管性青光眼。
Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1355-60. doi: 10.1007/s00417-012-2236-9. Epub 2012 Dec 19.
6
Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure.增生性糖尿病视网膜病变、视网膜中央静脉阻塞和眼缺血综合征新生血管性青光眼的小梁切除术:手术结果和失败的预测因素。
Indian J Ophthalmol. 2021 Nov;69(11):3341-3348. doi: 10.4103/ijo.IJO_1516_21.
7
Clinical Features of Japanese Patients with Central Retinal Vein Occlusion Complicated by Normal-Tension Glaucoma: A Retrospective Study.中心性视网膜静脉阻塞合并正常眼压性青光眼的日本患者的临床特征:一项回顾性研究。
Ophthalmologica. 2017;237(3):173-179. doi: 10.1159/000459636. Epub 2017 Mar 11.
8
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.抗血管内皮生长因子(VEGF)治疗是短期内新生血管性青光眼治疗的关键策略。
BMC Ophthalmol. 2016 Aug 30;16(1):150. doi: 10.1186/s12886-016-0327-9.
9
Glaucoma as a prognostic factor of central retinal vein occlusion: visual and anatomical outcomes and occurrence of ischaemic central retinal vein occlusion.青光眼作为视网膜中央静脉阻塞的预后因素:视力和解剖学结果以及缺血性视网膜中央静脉阻塞的发生。
Acta Ophthalmol. 2021 Jun;99(4):e523-e530. doi: 10.1111/aos.14608. Epub 2020 Oct 28.
10
Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.玻璃体内注射贝伐单抗联合全视网膜光凝治疗开角型新生血管性青光眼。
Eur J Ophthalmol. 2009 Nov-Dec;19(6):1028-33. doi: 10.1177/112067210901900620.

引用本文的文献

1
Retinal vein occlusions associated or complicated with glaucoma. Aspects of prediction and paths of progression.与青光眼相关或并发的视网膜静脉阻塞。预测方面和进展途径。
Rom J Ophthalmol. 2023 Jan-Mar;67(1):97-103. doi: 10.22336/rjo.2023.18.
2
Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?红细胞:在中央视网膜静脉阻塞发病机制中一个新描述的伙伴?
Int J Mol Sci. 2023 Jan 5;24(2):1072. doi: 10.3390/ijms24021072.
3
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.新生血管性青光眼:病因、发病机制、诊断与治疗的综述。
Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870.
4
A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion.关于视网膜静脉阻塞患者高眼压与青光眼关联的叙述性综述。
Ann Transl Med. 2022 Oct;10(19):1072. doi: 10.21037/atm-22-2730.
5
Assessing retinal vein occlusion based on color fundus photographs using neural understanding network (NUN).基于神经理解网络(NUN)的眼底彩照视网膜静脉阻塞评估。
Med Phys. 2023 Jan;50(1):449-464. doi: 10.1002/mp.16012. Epub 2022 Oct 24.
6
Etiology, pathogenesis, and diagnosis of neovascular glaucoma.新生血管性青光眼的病因、发病机制及诊断
Int J Ophthalmol. 2022 Jun 18;15(6):1005-1010. doi: 10.18240/ijo.2022.06.20. eCollection 2022.
7
Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.视网膜静脉闭塞之谜:静脉的血管活性和内皮素-1 的可能参与。
Biomed Res Int. 2017;2017:4816527. doi: 10.1155/2017/4816527. Epub 2017 Aug 20.
8
Neovascular glaucoma: a review.新生血管性青光眼:综述
Int J Retina Vitreous. 2016 Nov 14;2:26. doi: 10.1186/s40942-016-0051-x. eCollection 2016.
9
Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion.缺血性视网膜中央静脉阻塞并发症治疗的系统文献综述
BMC Ophthalmol. 2016 Jul 11;16:104. doi: 10.1186/s12886-016-0282-5.

本文引用的文献

1
Retinal vein occlusion and the optic disk.视网膜静脉阻塞与视盘。
Retina. 2012 Nov-Dec;32(10):2108-18. doi: 10.1097/IAE.0b013e31825620f2.
2
Natural history of central retinal vein occlusion: an evidence-based systematic review.视网膜中央静脉阻塞的自然病程:基于证据的系统评价。
Ophthalmology. 2010 Jun;117(6):1113-1123.e15. doi: 10.1016/j.ophtha.2010.01.060.
3
Retinal vein occlusion and angle closure: a retrospective case series.视网膜静脉阻塞和闭角型青光眼:回顾性病例系列。
J Glaucoma. 2010 Dec;19(9):643-9. doi: 10.1097/IJG.0b013e3181d12dea.
4
Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome.在剥脱综合征中,视网膜血管阻塞更常发生在病变更严重的眼中。
Eye (Lond). 2010 Apr;24(4):658-62. doi: 10.1038/eye.2009.152. Epub 2009 Jun 26.
5
Central retinal vein occlusion case-control study.视网膜中央静脉阻塞病例对照研究。
Am J Ophthalmol. 2007 Dec;144(6):858-863. doi: 10.1016/j.ajo.2007.07.036. Epub 2007 Oct 4.
6
Prevalent misconceptions about acute retinal vascular occlusive disorders.关于急性视网膜血管阻塞性疾病的普遍误解。
Prog Retin Eye Res. 2005 Jul;24(4):493-519. doi: 10.1016/j.preteyeres.2004.12.001.
7
Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.与视网膜中央静脉阻塞和半侧视网膜中央静脉阻塞相关的眼压异常。
Ophthalmology. 2004 Jan;111(1):133-41. doi: 10.1016/j.ophtha.2003.03.002.
8
Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes.青光眼患者房水中血管内皮生长因子水平升高。
J Glaucoma. 2002 Oct;11(5):406-10. doi: 10.1097/00061198-200210000-00006.
9
Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion.视网膜静脉阻塞中的杯盘比、眼压与原发性开角型青光眼
Ophthalmology. 2002 Feb;109(2):282-6. doi: 10.1016/s0161-6420(01)00922-8.
10
Evaluation of the clinical course of central retinal vein occlusion in eyes with and without glaucoma.青光眼患者与非青光眼患者视网膜中央静脉阻塞临床病程的评估。
Acta Ophthalmol Scand Suppl. 1997(224):16-7. doi: 10.1111/j.1600-0420.1997.tb00451.x.

已有青光眼患者发生视网膜中央静脉阻塞后的新生血管性青光眼。

Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma.

作者信息

Chen Hsi-Fu, Chen Min-Chi, Lai Chi-Chun, Yeung Ling, Wang Nan-Kai, Chen Henry Shen-Lih, Ku Wan-Chen, Wu Shiu-Chen, Chang Shirley H L, Chuang Lan-Hsin

机构信息

Department of Ophthalmology, Chang Gung Memorial Hospital, 222 Mai-Chin Rd, Keelung 204, Taiwan.

出版信息

BMC Ophthalmol. 2014 Oct 5;14:119. doi: 10.1186/1471-2415-14-119.

DOI:10.1186/1471-2415-14-119
PMID:25282154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4193090/
Abstract

BACKGROUND

To determine the outcome of central retinal vein occlusion (CRVO) in pre-existing glaucoma and the predisposing factors of developing neovascular glaucoma (NVG).

METHODS

We retrospectively assessed a pre-existing glaucoma CRVO group and a non-glaucoma CRVO group to elucidate the demographics, clinical course and ocular parameters of these two cohorts. Among the pre-existing glaucoma cases, the predisposing factors for the development of NVG were monitored, including the retinal capillary non-perfusion status, intraocular pressure (IOP) and best-corrected visual acuity (BCVA) at presentation.

RESULTS

Of 642 CRVO patients reviewed in this 10-year cohort study, 60 (9.3%) had pre-existing glaucoma at a mean follow-up of 30.8 months, including 28 (4.4%) primary open angle glaucoma (POAG), 27 (4.2%) primary angle closure glaucoma (PACG), and 5 (0.8%) normal tension glaucoma (NTG) cases. Although the presence of glaucoma in the CRVO eyes was not significantly associated with the risk of developing NVG, the incidence of developing NVG in pre-existing glaucoma eyes was significantly higher in the group with IOP greater than 20 mmHg at CRVO presentation (P = 0.02, Chi-square test) as well as in the ischemic CRVO group compared to the non-ischemic patients (P = 0.005, Fisher's exact test). Overall, 20% of pre-existing glaucoma patients needed glaucoma surgery after a CRVO event, including 11.7% of patients who developed iris neovascularisation (INV) and 8.3% of patients who developed a high IOP without INV.

CONCLUSIONS

Both the retinal non-perfusion status and uncontrolled IOP contribute to NVG in patients with pre-existing glaucoma after CRVO. Following CRVO, glaucoma surgery is necessary for pre-existing glaucoma cases with intractable elevated IOP with or without INV.

摘要

背景

确定已有青光眼患者发生视网膜中央静脉阻塞(CRVO)的结局以及发生新生血管性青光眼(NVG)的易感因素。

方法

我们回顾性评估了已有青光眼的CRVO组和非青光眼的CRVO组,以阐明这两个队列的人口统计学、临床病程和眼部参数。在已有青光眼的病例中,监测发生NVG的易感因素,包括就诊时的视网膜毛细血管无灌注状态、眼压(IOP)和最佳矫正视力(BCVA)。

结果

在这项为期10年的队列研究中纳入的642例CRVO患者中,60例(9.3%)在平均30.8个月的随访期内已有青光眼,其中28例(4.4%)为原发性开角型青光眼(POAG),27例(4.2%)为原发性闭角型青光眼(PACG),5例(0.8%)为正常眼压性青光眼(NTG)。尽管CRVO患眼中青光眼的存在与发生NVG的风险无显著相关性,但已有青光眼的患眼中,CRVO就诊时IOP大于20 mmHg的组发生NVG的发生率显著更高(P = 0.02,卡方检验),与非缺血性患者相比,缺血性CRVO组发生NVG的发生率也更高(P = 0.005,Fisher精确检验)。总体而言,20%的已有青光眼患者在CRVO事件后需要进行青光眼手术,包括11.7%发生虹膜新生血管(INV)的患者和8.3%未发生INV但眼压升高的患者。

结论

视网膜无灌注状态和未控制的眼压均促成已有青光眼患者CRVO后发生NVG。CRVO后,对于已有青光眼且IOP顽固升高伴或不伴INV的病例,有必要进行青光眼手术。